Relationship Between Cognitive Functions and Oxytocin Levels in Patients with Multivessel Coronary Artery Disease
https://doi.org/10.52667/2712-9179-2025-5-2-26-30
Abstract
This study investigates the relationship between cognitive function and oxytocin levels in blood and saliva among male patients with multivessel coronary artery disease (CAD). Existing literature highlights a significant association between CAD and cognitive impairment, with prevalence rates varying widely due to inconsistent diagnostic criteria. Objective: To determine the relationship between cognitive function and oxytocin levels in blood and saliva among patients with multivessel coronary artery disease. Methods: Our research involved 91 male patients undergoing coronary artery bypass grafting, excluding those with concomitant diseases or significant cognitive deficits. Neuropsychological assessments were conducted using validated screening scales, including the Mini-Mental State Examination (MMSE) and Frontal Assessment Battery (FAB). Oxytocin levels were measured through enzyme-linked immunosorbent assay (ELISA). Results indicated significant correlations between cognitive performance and oxytocin levels, with direct relationships observed for MMSE and word recall tests, and inverse relationships for the Schulte test. Discussion: These findings suggest that oxytocin may serve as a potential biomarker for vascular cognitive impairment in CAD patients, offering a rapid and objective diagnostic tool that could enhance clinical practice. Conclusion: Ultimately, this study contributes to the understanding of cognitive deficits in CAD and supports the exploration of oxytocin as a diagnostic biomarker.
About the Authors
Olga V. MikhailovaRussian Federation
Krasnoyarsk, 660022.
Marina M. Petrova
Russian Federation
Krasnoyarsk, 660022.
Olga L. Lopatina
Russian Federation
Krasnoyarsk, 660022.
References
1. Liang, X.; Huang, Y.; Han, X. Associations between coronary heart disease and risk of cognitive impairment: A meta-analysis. Brain Behav. 2021, 11:e02108. doi: 10.1002/brb3.2108.
2. Zhao, E.; Lowres, N.; Woolaston, A. Prevalence and patterns of cognitive impairment in acute coronary syndrome patients: A systematic review. Eur. J. Prev. Cardiol. 2020, 27:284–293. doi: 10.1177/2047487319878945.
3. Kasprzak, D.; Kaczmarek-Majer, K.; Rzeźniczak, J. Cognitive impairment in cardiovascular patients after myocardial infarction: prospective clinical study. J Clin Med. 2023, 12(15):4954. doi: 10.3390/jcm12154954.
4. Xie, W.; Zheng, F.; Yan, L.; Zhong, B. Cognitive decline before and after incident coronary events. J. Am. Coll. Cardiol. 2019, 73:3041–3050. doi: 10.1016/j.jacc.2019.04.019.
5. Gaalema, D.E.; Mahoney, K.; Ballon, J.S. Cognition and exercise: General overview and implications for cardiac rehabilitation. J. Cardiopulm. Rehabil. Prev. 2021, 41:400–406. doi: 10.1097/HCR.0000000000000644.
6. Visseren, F.L.; Mach, F.; Smulders, Y.M. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2021, 42:3227–3337. doi: 10.1093/eurheartj/ehab484.
7. Zimnitskaya, O.V.; Mozheyko, E.Yu.; Petrova, M.M. Biomarkers of vascular cognitive dysfunction. Cardiovascular Therapy and Prevention. 2021, 20(3):2677. doi: 10.15829/1728-8800-2021-2677.
8. Atkinson, A.J.; Colburn, W.A.; DeGruttola, V.G. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001, 69:89-95. doi: 10.1067/mcp.2001.113989
9. Abramova, O.; Zorkina, Y.; Ushakova, V. The role of oxytocin and vasopressin dysfunction in cognitive impairment and mental disorders. Neuropeptides. 2020, 83:1020-1079. doi: 10.1016/j.npep.2020.102079.
10. Striepens, N.; Schröter, F.; Stoffel-Wagner, B. Oxytocin enhances cognitive control of food craving in women. Human Brain Mapping. 2016, 37(12):4276–4285. doi: 10.1002/hbm.23308.
11. Young Kuchenbecker, S.; Pressman, S.D.; Celniker, J. Oxytocin, cortisol, and cognitive control during acute and naturalistic stress. Stress. 2021, 24(4):370–383. doi: 10.1080/10253890.2021.1876658/
12. Quinn, M.E.; Stanton, C.H.; Slavich, G.M.; Joormann, J. Executive control, cytokine reactivity to social stress, and depressive symptoms: Testing the social signal transduction theory of depression. Stress. 2020, 23(1):60–68. doi: 10.1080/10253890.2019.1641079.
Review
For citations:
Mikhailova O.V., Petrova M.M., Lopatina O.L. Relationship Between Cognitive Functions and Oxytocin Levels in Patients with Multivessel Coronary Artery Disease. Personalized Psychiatry and Neurology. 2025;5(2):26-30. https://doi.org/10.52667/2712-9179-2025-5-2-26-30